Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1β, and the production of interferon γ in the absence of IL-12 during DC-T cell cognate interaction: A new role for fas ligand in inflammatory responses

Journal of Experimental Medicine

Volumn 192, Issue 11, 2000, Pages 1661-1668

  Rescigno, Maria ^a   Piguet, Vincent ^b   Valzasina, Barbara ^a   Lens, Suzanne ^c   Zubler, Rudolf ^b   French, Lars ^b   Kindler, Vincent ^b   Tschopp, Jurg ^c   Ricciardi Castagnoli, Paola ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Dendritic cells; Fas; FLIP; Interferon ; Interleukin 1

Indexed keywords

ANTIBODY; CD34 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FAS LIGAND PROTEIN; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MITOGENS; PHENOTYPE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034606290     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.11.1661     Document Type: Article

References (29)

1. Dendritic cells and the control of immunity
2. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures
3. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway
4. + T cells
5. Fas and FasL in the homeostatic regulation of immune responses
6. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
7. Caspase activation is required for T cell proliferation
8. Inhibition of fas death signals by FLIPs
9. Inhibition of death receptor signals by cellular FLIP
10. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways
11. Dendritic cell survival and maturation are regulated by different signaling pathways
12. Fas-FasL interactions: A common pathogenetic mechanism in organ-specific autoimmunity
13. + dendritic cell precursor
14. Dendritic cells as natural adjuvants
15. Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors
16. Sensitive method for measuring apoptosis and cell surface pheno-type in human thymocytes by flow cytometry
17. Nef-induced CD4 degradation: A diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of β-COP in endosomes
18. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: Inhibition by bisindolylmaleimide
19. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells
20. + lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway
21. Fas ligation triggers apoptosis in macrophages but not endothelial cells
22. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo
23. The duration of antigenic stimulation determines the fate of naive and effector T cells
24. Fas transduces activation signals in normal human T lymphocytes
25. Expression of the Fas ligand in cells of T cell lineage
26. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
27. Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus
28. The role of Fas in autoimmune diabetes
29. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts